Clinical Education Alliance Expands World-Class Brands and Innovation Globally Through Strategic Investment by The Riverside Company

Share Article

The Riverside Company has signed a definitive agreement to purchase a majority stake of CEA from Renovus Capital

Continuing Education Alliance logo

Continuing Education Alliance logo

"Together, our education enables improvements in healthcare professionals’ ability to provide superior care and positively impact patient health outcomes." - Dan Cox, CEO of CEA

Clinical Education Alliance® (CEA), which includes the premier educational brands of Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), ProCE, and Global Medical Education (GME), announced today that The Riverside Company, a global private equity firm, has signed a definitive agreement to purchase a majority stake of CEA from Renovus Capital.

CEA, a pioneer in continuing medical education and continuing education during the last 2 decades, is a global market leader in hematology, oncology, infectious disease, immunology, psychiatry, and neurology education. The company is recognized for both its live meetings and array of innovative, interactive online educational programs, including its personalized education and disease-specific and patient-specific point-of-care decision support tools, which have been honored with the Alliance for Continuing Education in the Health Professions’ Innovative Format Award.

CEA’s vast healthcare professional reach encompasses physicians, pharmacists, nurses, pharmacy technicians, physician assistants, and nurse practitioners and includes brands exclusively focusing on each healthcare discipline, tailoring to the unique educational needs and scope of practice of each of our learners.

“We are thrilled by the strategic investment and the confidence Riverside has shown in our organization,” said Dan Cox, CEO of CEA. “Our goal is to expand our world-class brands while leveraging each other’s strengths, innovating for the benefit of all healthcare professionals. Together, our education enables improvements in healthcare professionals’ ability to provide superior care and positively impact patient health outcomes. Riverside provides CEA with additional capital to achieve our goals and we are extremely excited for our partnership.”

“CEA’s digital-based education programs are more critical than ever and continue to offer healthcare professionals the learning resources they need especially during the COVID-19 pandemic,” said Riverside Partner Peter Tsang. “Our partnership will expand CEA’s therapeutic areas and learner base as well as increase the company’s technological offerings.”

Cain Brothers served as the sell-side advisor and DLA Piper served as legal counsel to CEA. Jones Day served as legal counsel to Riverside.

About Clinical Education Alliance
CEA is the global leader in the development of innovative enduring, virtual, and live education as well as decision support resources. Integrating personalization and state-of-the-art digital marketing programs, CEA provides continuing medical education for the entire healthcare team with the goal of improving patient outcomes. For more information, visit ClinicalEducationAlliance.com.

About Riverside Capital
The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 650 investments. The firm’s international private equity and structured capital portfolios include more than 110 companies.

Contact:
Barb Bernard
Sr. Director of Marketing
Clinical Education Alliance
bbernard@clinicaloptions.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Carlton Sanderson

Tradd Sanderson
Visit website